- Enabling Advanced 4D Clinical Application to Run Concurrently on Existing
PACS Workstations
PRINCETON JUNCTION, N.J., June 4 /PRNewswire/ -- EDDA Technology today
announced that it is introducing IQQA(R)-Liver Enterprise for contrast
Multi-Detector CT (MDCT) abdominal imaging at the upcoming Annual Meeting
of the Society for Imaging Informatics in Medicine (SIIM). The enterprise
software solution enables the advanced 4D imaging application, which
supports physicians' real-time evaluation of liver and hepatic lesions, to
run concurrently on hospital's existing PACS workstations.
IQQA(R)-Liver addresses the clinical challenge faced by physicians in
efficiently dealing with tremendous data volume from contrast MDCT images
of liver. Combining advanced image analysis algorithms and powerful
visualization tools, the software supports physicians to quickly and
effectively distill critical diagnostic information from data volume of
extraordinary size. It performs automatic anatomic phase registration to
allow simultaneous visualization and easy cross-referencing of lesion
location and characteristics across the different phases. IQQA(R)-Liver
further provides 3D segmentation and measurement tools for the
visualization and analysis of liver lesions, hepatic vascular structures,
as well as liver lobes. This volumetric analysis not only provides
physicians with a powerful visualization aid, but also offers
quantification tools to support their clinical decision making and patient
care management.
IQQA(R)-Liver Enterprise is powered with the same enabling engine
technology behind IQQA(R)-Chest Enterprise for digital radiography which
the company introduced at RSNA 2006. The IQQA(R) Enterprise Engine
(IQQA(R)-EE) aims to redefine how advanced clinical application can be
accessed by radiologists and managed by radiology IT. Radiologists can now
enjoy immediate access to the full real-time 3D/4D functionality of
advanced clinical applications at existing PACS viewing stations. In
addition, since the solution does not require code level integration with
existing hospital PACS environment, application installation is completed
quickly by simply setting up network communication. Possible additional
maintenance resources of having to change with periodic PACS software
upgrade are also saved.
"EDDA is committed to delivering new generation of diagnostic decision
support solutions, which not only include advanced clinical applications to
improve early detection, early diagnosis and precise treatment of lethal
diseases, but also very importantly include innovations for ease of access
of such applications," says Dr. Jian-Zhong Qian, President and CEO of EDDA
Technology. "From the success of development of IQQA(R)-Chest Enterprise to
IQQA(R)-Liver Enterprise, IQQA(R)-EE demonstrates a new economic way to
integrate 2D/3D/4D applications with virtually any existing hospital PACS
systems without code level integration. Advanced imaging applications in
this way can readily run concurrently on hospital's existing PACS viewing
stations with minimum installation and maintenance effort. Considering the
trend of numerous advanced 3D/4D applications that already exist and many
more that are emerging, the impact of such accessibility enabling
technology will be significant."
Liver disease is among the 10 major causes of death in the US,
according to the American Liver Foundation. There are 25,000,000 Americans
afflicted by liver disease. Primary liver cancer, with approximately
1,000,000 cases reported every year in the world, is one of the most common
malignancies. Liver metastasis tumors also occur frequently, as any primary
cancer location can deposit metastases in the liver. As the liver is
generally the first site of metastatic spread, aggressive surgical
intervention at an early stage of metastasis results in a reported 25-40%
five-year survival rate.
The IQQA(R)-Liver software has been in clinical use in several luminary
Chinese hospitals for liver cancer detection, diagnosis and treatment
planning purposes, including Eastern Hepatobiliary Surgery Hospital in
Shanghai, Peking Union Medical College Hospital in Beijing, Shanghai Ruijin
Hospital, and Beijing Youyi Hospital.
The IQQA(R) Enterprise Engine has been successfully integrated to run
in numerous PACS environments including AGFA, GE, Kodak, McKesson, Philips
and etc.
EDDA Technology will be exhibiting the IQQA(R) Family of Products in
Booth #710 at the Annual Meeting of the Society for Imaging Informatics in
Medicine (SIIM), Providence, RI, June 7 - June 9, 2007.
About EDDA Technology
EDDA Technology, Inc. is an innovative clinical computer solution
provider in diagnostic imaging and analysis. EDDA offers a series of new
generation software products to enable early detection of diseases, and
enhance efficiency and precision in diagnosis and treatment. EDDA's goal is
to with broad accessibility deliver advanced information analysis
technologies that improve clinical workflow and accuracy. A privately held
Delaware corporation, EDDA is headquartered in Princeton Junction, New
Jersey, and has a subsidiary in Shanghai, China. In April 2006, EDDA
entered into a strategic partnership with Philips Medical Systems to
provide advanced digital radiography solutions to assist in the detection
of lung lesions. IQQA is a registered trademark of EDDA Technology. For
further information, please log on to http://www.edda- tech.com, or call
609-936-8282.
SOURCE EDDA Technology
 back to top
Related links:
http://www.edda-tech.com
CONTACT:
Xiaolan Zeng, +1-609-936-8282 ext. 106,
xzeng@edda-tech.com
|
